drugset / Trial / NCT02912195
Intravenous Lidocaine Versus Morphine for Severe Pain in the ED
RandomizedParallel-groupOpen-labelTreatment
Summary
Objective: Evaluate the analgesic efficacy of intravenous (IV) lidocaine versus provider chosen dose of IV morphine for the treatment of severe pain in the emergency department. Study design: Open-label, randomized controlled pilot study.
Timeline
- Start
- 2016-03
- Primary completion
- 2016-09
- Completion
- 2016-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lidocaine | Other / unclassified | 75 mg | Intravenous |
| Subject | Lidocaine | Other / unclassified | 100 mg | Intravenous |
| Subject | Lidocaine | Other / unclassified | 150 mg | Intravenous |
| Comparator | Morphine | Other / unclassified | — | Intravenous |
Indications
No indication recorded.